The antianginal ranolazine fails to improve glycaemia in obese liver-specific pyruvate dehydrogenase deficient male mice.

Saved in:
Bibliographic Details
Title: The antianginal ranolazine fails to improve glycaemia in obese liver-specific pyruvate dehydrogenase deficient male mice.
Authors: Saed CT; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada., Tabatabaei Dakhili SA; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada., Greenwell AA; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada., Chan JSF; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada., Yang K; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada., Gopal K; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada., Eaton F; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada., Al Batran R; Faculty of Pharmacy, Université de Montréal, Quebec, Canada., Ussher JR; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada.
Source: Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2023 Aug; Vol. 133 (2), pp. 194-201. Date of Electronic Publication: 2023 Jun 22.
Publication Type: Journal Article
Journal Info: Publisher: Blackwell Country of Publication: England NLM ID: 101208422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-7843 (Electronic) Linking ISSN: 17427835 NLM ISO Abbreviation: Basic Clin Pharmacol Toxicol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1742-7843
DOI:10.1111/bcpt.13906